Predictive value of increased plasma levels of fibronectin in gestational hypertension

American Journal of Obstetrics and Gynecology
V C BallegeerD Collen

Abstract

Blood pressure, proteinuria, and plasma fibronectin and plasminogen activator inhibitor-1 levels were measured in 120 apparently healthy normotensive primigravid women during the first, second, and third trimesters of pregnancy and 2 days post partum. Thirty-two women developed hypertension (diastolic blood pressure greater than or equal to 90 mm Hg) that in 17 women was associated with proteinuria (greater than 0.3 gm/day). Fibronectin levels were 83% +/- 22% of normal (mean +/- SD) during the first trimester and 75% +/- 20% at term in the healthy women but increased from 94% +/- 36% to 187% +/- 36% in the women who developed gestational hypertension (with or without proteinuria) (p less than 0.0001). Plasminogen activator inhibitor-1 levels increased from 26 +/- 19 ng/ml to 110 +/- 86 ng/ml in healthy women and from 32 +/- 35 ng/ml to 290 +/- 90 ng/ml in hypertensive women (p less than 0.001). Increased levels of fibronectin at 25 to 36 weeks of pregnancy (greater than or equal to mean + 2 SD of the healthy women, or greater than 140%) were found in 31 of the 32 women with gestational hypertension with or without proteinuria and in 5 of the 88 healthy women (sensitivity 96%, specificity 94%). Fibronectin levels increased 3.6 ...Continue Reading

References

Aug 1, 1987·American Journal of Obstetrics and Gynecology·A A SalehE F Mammen
Oct 1, 1987·Seminars in Thrombosis and Hemostasis·P G de Groot, J J Sixma
May 1, 1986·American Journal of Obstetrics and Gynecology·J LazarchickC B Loadholt
Apr 1, 1985·European Journal of Obstetrics, Gynecology, and Reproductive Biology·W GraningerF Nasr
Jul 1, 1985·The Journal of Clinical Investigation·B A PussellJ A Charlesworth
Apr 3, 1971·British Medical Journal·J BonnarA S Douglas
Dec 1, 1984·American Journal of Obstetrics and Gynecology·T M StubbsE O Horger
Mar 24, 1955·Annals of the New York Academy of Sciences·C S WRIGHT, M C DODD

❮ Previous
Next ❯

Citations

Feb 1, 1995·American Journal of Obstetrics and Gynecology·M J KupfermincM L Socol
Jan 31, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·G G ZeemanA A Kraayenbrink
Nov 1, 1996·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M Shaarawy, H E Didy
Sep 1, 1999·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S S SudN K Ganguly
Dec 2, 1999·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·D M PaternosterP V Grella
Mar 16, 2000·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M Shaarawy, A M Abdel-Magid
Feb 13, 2001·Atherosclerosis·K S SongS H Jee
Jul 10, 2003·Clinics in Laboratory Medicine·Deirdre J LyellLinda C Giudice
Mar 27, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A C BolteG A Dekker
Dec 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D M PaternosterM Plebani
May 30, 1998·European Journal of Obstetrics, Gynecology, and Reproductive Biology·T KraussH G Augustin
May 30, 1998·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M DreyfusJ M Foidart
May 24, 2003·Best Practice & Research. Clinical Haematology·Katarina A Bremme
Feb 1, 1995·Obstetrical & Gynecological Survey·E F Magann, J N Martin
Feb 1, 1996·The Journal of Obstetrics and Gynaecology Research·M GaoY Takeda
Mar 1, 1997·American Journal of Reproductive Immunology : AJRI·K P Conrad, D F Benyo
Mar 21, 2001·Clinical Chemistry and Laboratory Medicine : CCLM·M Shaarawy, M E Salem
Jan 9, 2004·Journal of Perinatal Medicine·Mustafa BasbugMehmet Tayyar
Jan 1, 1994·Journal of Perinatal Medicine·C SenN Tolun
Feb 1, 1992·American Journal of Obstetrics and Gynecology·D B BrubakerD Marinoff
Feb 1, 1992·American Journal of Obstetrics and Gynecology·V C BallegeerA M Criel
Sep 1, 1993·American Journal of Obstetrics and Gynecology·J MasséM Bélanger
Jul 1, 1991·American Journal of Obstetrics and Gynecology·G A Dekker, B M Sibai
Dec 1, 1994·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·D PaternosterA Girolami
Sep 1, 1995·Baillière's Clinical Obstetrics and Gynaecology·G A Dekker
Sep 1, 1994·Baillière's Clinical Haematology·S D Wright, E G Tuddenham
Sep 1, 1992·Baillière's Clinical Obstetrics and Gynaecology·R M Silver, D W Branch
Oct 12, 2010·American Journal of Obstetrics and Gynecology·Antonio FarinaTakashi Okai
Aug 3, 2014·American Journal of Obstetrics and Gynecology·Juha RasanenMichael G Gravett
Sep 19, 2002·American Journal of Obstetrics and Gynecology·María Eugenia ChavarríaAlejandro Reyes
Aug 11, 2007·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·G SimonazziN Rizzo
Sep 5, 2006·Prenatal Diagnosis·Antonio FarinaTakashi Okai
Jan 31, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Tahsin AydinNiyazi Cenk Sayin
Feb 16, 2008·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Jane WoolcockRobert Ogle
Feb 15, 2019·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·Flávia Campos LucenaLuci Maria SantAna Dusse
Jan 1, 1996·British Journal of Obstetrics and Gynaecology·S C LeesonK J Baldwin
May 1, 1993·British Journal of Obstetrics and Gynaecology·E Eneroth-GrimforsS Bevegård
Jun 1, 1993·British Journal of Obstetrics and Gynaecology·M H Sullivan, M G Elder
Dec 1, 1991·Annals of Medicine·M G Elder
Jun 26, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Simmi Kharb
Apr 30, 1998·Obstetrical & Gynecological Survey·E van Beck, L L Peeters

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.